CN
Genecast presented 2 studies at ASCO GI 2024，including 2 posters：
| ID | Title |
| N13 | Randomized Controlled Trial of CAPEOX vs ObseRvation in Early-stage Colorectal Cancer Patients with Positive MRD After CurativE Surgery (CAREME) |
| L20 | Incidence and genomic characteristics of gene fusions in a large Chinese colorectal cancer |
#02-01/02, The Kendall, 50 Science Park Road. Singapore Science Park 2, Singapore 117406
Tel: +65 6047 0252 ; Email: info@genecast.com.sg
Copyright © 2014-2026 Genecast Group Inc. | Privacy Policy
